Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Grabe

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|June 26, 2020
Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer ScreeningNicolas Wentzensen, Bernd Lahrmann, Megan A Clarke, et al.
The Journal of Clinical Investigation|May 3, 2013
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomasEfterpi Kostareli, Dana Holzinger, Olga Bogatyrova, et al.
Oncotarget|February 2, 2017
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapySimon Laban, Gregor Giebel, Niklas Klümper, et al.
BMC Cancer|October 7, 2021
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinomaMarcell Tóth, Lilija Wehling, Lena Thiess, et al.
Research Square|March 17, 2025
Closing the Automation Gap: Robust AI for Dual-Stain Cervical Cancer Screening TriageBernd Lahrmann, Andreas Keil, Felipe Miranda Ruiz, et al.
Acta Neuropathologica Communications|March 19, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomasCatharina Lotsch, Nicoletta Giuliani Canizales, Lena Jassowicz, et al.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
International Journal of Cancer|March 3, 2016
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patientsAndreas Mock, Christoph Geisenberger, Christian Orlik, et al.
Nature Communications|February 19, 2021
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patientsMaria Xydia, Raheleh Rahbari, Eliana Ruggiero, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|June 26, 2020
Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer ScreeningNicolas Wentzensen, Bernd Lahrmann, Megan A Clarke, et al.
The Journal of Clinical Investigation|May 3, 2013
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomasEfterpi Kostareli, Dana Holzinger, Olga Bogatyrova, et al.
Oncotarget|February 2, 2017
MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapySimon Laban, Gregor Giebel, Niklas Klümper, et al.
BMC Cancer|October 7, 2021
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinomaMarcell Tóth, Lilija Wehling, Lena Thiess, et al.
Research Square|March 17, 2025
Closing the Automation Gap: Robust AI for Dual-Stain Cervical Cancer Screening TriageBernd Lahrmann, Andreas Keil, Felipe Miranda Ruiz, et al.
Acta Neuropathologica Communications|March 19, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomasCatharina Lotsch, Nicoletta Giuliani Canizales, Lena Jassowicz, et al.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
International Journal of Cancer|March 3, 2016
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patientsAndreas Mock, Christoph Geisenberger, Christian Orlik, et al.
Nature Communications|February 19, 2021
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patientsMaria Xydia, Raheleh Rahbari, Eliana Ruggiero, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Pageof 11